Cadaveric bone marrow and spleen cells for transplantation

Bone Marrow Transplantation

Volumn 21, Issue 1, 1998, Pages 79-84

  Soderdahl G ^a   Tammik, C ^a   Remberger, M ^a   Ringden O ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Bone marrow; Cadaveric; Hematopoietic stem cells; Spleen cells; Transplantation

Indexed keywords

CD34 ANTIGEN;

ARTICLE; BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; BURST FORMING UNIT E; CADAVER DONOR; CELL NUCLEUS; CELL SELECTION; CELL TRANSPLANTATION; CELL VIABILITY; COLONY FORMING UNIT GEMM; COLONY FORMING UNIT GM; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUMBAR VERTEBRA; MONONUCLEAR CELL; PRIORITY JOURNAL; RIB; SPLEEN CELL; STEM CELL; STERNUM; T LYMPHOCYTE; THORACIC SPINE; VERTEBRA;

EID: 2642710915     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701039     Document Type: Article

References (24)

1. Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation. Parts I and II. New Engl J Med 1975; 292: 832-843 and 895-902.
2. Marks DI, Cullis JO, Ward KN et al. Allogenic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
3. Ringdén O, Remberger M, Persson U et al. Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings. Bone Marrow Transplant 1995; 15: 619-625.
4. Downie TR, Hows JM, Gore SM et al. A survey of use of unrelated donor bone marrow transplantation at 46 centers worldwide, 1983-93. International Unrelated Search and Transplant (IMUST) Study. Bone Marrow Transplant 1995; 15: 499-503.
5. Rao AS, Thomson AW, Shapiro R, Starzl TE. Chimerism after whole organ transplantation: its relationship to graft rejection and tolerance induction. Curr Opin Nephrol Hypertens 1994; 3: 589-595.
6. Wren SM, Nalesnik M, Hronakes ML et al. Mixed chimerism to induce tolerance for solid organ transplantation. J Pediatr Surg 1991; 26: 439-443.
7. Sykes M, Sachs DH. Mixed allogenic chimerism as an approach to transplantation tolerance. Immunol Today 1988; 9: 23-27.
8. Fontes P, Rao AS, Demetris AJ et al. Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet cell transplantation. Lancet 1994; 344: 151-155.
9. Shapiro R, Rao AS, Fontes P et al. Combined kidney/bone marrow transplantation - evidence of augmentation of chimerism. Transplantation 1995; 59: 306-309.
10. Monaco AP, Wood ML. Studies on heterologous antilymphocyte serum in mice. VII. Optimal cellular antigen for induction of immunologic tolerance with antilymphocyte serum. Transplant Proc 1970; 2: 489-496.
11. Caridis DT, Liegeois A, Barrett I, Monaco AP. Enhanced survival of canine renal allografts of ALS-treated dogs given bone marrow. Transplant Proc 1973; 5: 671-674.
12. Thomas FT, Carver FM, Foil MB et al. Long-term incompatible kidney survival in outbred higher primates without chronic immunosuppression. Ann Surg 1983; 198: 370-378.
13. Barber WH, Mankin JA, Laskow DA et al. Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients. Transplantation 1991; 51: 70-75.
14. Rybka WB, Fontes PA, Rao AS et al. Hematopoietic progenitor cell content of vertebral body marrow used for combined solid organ and bone marrow transplantation. Transplantation 1995; 59: 871-874.
15. Mugishima H, Terasaki P, Sueyoshi A. Bone marrow from cadaver donors for transplantation. Blood 1985; 65: 392-396.
16. Southard JH, Belzer FO. Organ preservation. Annu Rev Med 1995; 46: 235-247.
17. 2 microglobulin and by lipopolysaccharide. Scand J Immunol 1976; 5: 891-900.
18. Loken M. Immunofluorescence techniques. In: Molamed MR, Lindmo T, Mendelsohn ML (eds). Flow Cytometry and Sorting, 2nd edn. New York: Wiley-Liss, 1990, p 341.
19. Ringdén O, Potter MN, Oakhill A et al. Transplantation of peripheral blood progenitor cells from unrelated donors. Bone Marrow Transplant 1996; 17 (Suppl. 2): S62-S64.
20. Ek S, Ringdén O, Markling L et al. Effects of cryopreservation on subsets of fetal liver cells. Bone Marrow Transplant 1993; 11: 395-398.
21. Prentice HG, Blacklock HAA, Janossy G et al. Depletion of T lymphocytes in donor marrow prevents significant graft-versus-host disease in matched allogeneic leukaemic marrow transplant recipients. Lancet 1984; i: 472-475.
22. Ringdén O, Pihlstedt P, Markling L et al. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221-226.
23. Sykes M, Chester CH, Sachs DH. Protection from graft-versus-host disease in fully allogenic chimeras by prior administration of T cell-depleted syngenic bone marrow. Transplantation 1988; 46: 327-330.
24. Moses RD, Orr KS, Bacher JD et al. Cardiac allograft survival across major histocompatibility complex barriers in the rhesus monkey following T-lymphocyte-depleted autologous marrow transplantation. II Prolonged allograft survival with extensive marrow T cell depletion. Transplantation 1989; 47: 435-444.